Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular DegenerationTwelve-Week Results of an Uncontrolled Open-Label Clinical Study - Concepedia

Concepedia

Publication | Open Access

Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular DegenerationTwelve-Week Results of an Uncontrolled Open-Label Clinical Study

DOI Full Paper Access

667

Citations

49

References

2005

Year

S. Michels, Philip J. Rosenfeld, C PULIAFITO, Elliott M. Marcus, A. Venkatraman

Ocular DiseaseOphthalmologyExperimental OphthalmologyAge-related DiseasesSystemic BevacizumabGlaucomaMedicine

References

	Year	Citations

Page 1